Geron Corporation GERN
1.04 USD +0.10 (+11.29%)
Nov 4, 2026, 2:46 PM EST
0.9614 Day range 1.05
0.84 52-week range 2.01
- YTD
- -21.59%
- 1 year
- -10.00%
Analyst view
Price target (mean) 4.25 +310.6% upside
Now 1.04
- Target (low)
- 3.00
- Target (mean)
- 4.25
- Target (high)
- 6.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy1
- Buy3
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.01 | -0.01 – -0.01 | -0.03 | +66.7% | 60.69M | +28.5% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.0212 | +100.0% | 66.27M | +38.0% | 1 |
| Current year | -0.02 | -0.02 – -0.02 | -0.1031 | +80.6% | 236.28M | +28.5% | 1 |
| Next year | 0.04 | 0.04 – 0.04 | -0.02 | +300.0% | 341.96M | +44.7% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 5, 2025 | Needham | Maintained | Buy | Buy |
| May 8, 2025 | Scotiabank | Downgrade | Sector Outperform | Sector Perform |
| Mar 12, 2025 | Needham | Reiterated | Buy | Buy |
| Mar 12, 2025 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Feb 27, 2025 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Feb 27, 2025 | Stifel | Maintained | Buy | Buy |
| Feb 27, 2025 | Barclays | Maintained | Overweight | Overweight |
| Feb 27, 2025 | Needham | Maintained | Buy | Buy |
| Feb 26, 2025 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Feb 18, 2025 | B. Riley Securities | Maintained | Buy | Buy |
| Jan 13, 2025 | Needham | Maintained | Buy | Buy |
| Dec 13, 2024 | Needham | Reiterated | Buy | Buy |
| Dec 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 5, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Oct 16, 2024 | Scotiabank | Initiated | — | Sector Outperform |
| Sep 9, 2024 | Leerink Partners | Initiated | — | Outperform |
| Aug 9, 2024 | Needham | Reiterated | Buy | Buy |
| Jul 26, 2024 | Needham | Reiterated | Buy | Buy |
| Jun 11, 2024 | Barclays | Initiated | — | Overweight |
| Jun 10, 2024 | Barclays | Initiated | — | Overweight |
| Jun 10, 2024 | Stifel | Maintained | Buy | Buy |
| Jun 7, 2024 | Needham | Maintained | Buy | Buy |
| Jun 7, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| May 2, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 30, 2024 | Baird | Downgrade | Outperform | Neutral |
| Apr 29, 2024 | TD Cowen | Initiated | — | Buy |
| Apr 11, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 10, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Mar 15, 2024 | Needham | Maintained | Buy | Buy |